Variable | Total cohort n=9566 | Multimorbidity class 1 (severe) 591 (6.5%) | Multimorbidity class 2 (moderate) 4301 (47.6%) | Multimorbidity class 3 (mild) 4147 (45.9%) | P value†|
---|---|---|---|---|---|
Age, mean (SD) | 64.1 (11.9) | 74.8 (9.3) | 68.8 (10.3) | 57.7 (10.5) | <0.001* |
Women, n (%) | 2384 (24.9) | 177 (30.0) | 1274 (29.7) | 803 (19.4) | <0.001* |
IMD, mean (SD) | 23.0 (15.7) | 24.0 (16.2) | 22.3 (15.2) | 23.7 (16.1) | 0.04 |
BMI, mean(SD) | 28.7 (6.0) | 29.8 (5.4) | 28.9 (5.5) | 28.2 (6.5) | <0.001* |
Ethnicity (Caucasian), n (%) | 8136 (85.1) | 507 (94.8) | 3639 (94.2) | 3530 (93.3) | 0.41 |
Ex/current smoking status, n (%) | 6248 (65.3) | 368 (64.6) | 2709 (64.2) | 5979 (67.2) | <0.001* |
NSTEMI, n (%) | 5658 (59.2) | 508 (86.0) | 2870 (66.7) | 2046 (49.3) | <0.001* |
STEMI, n (%) | 3908 (40.8) | 83 (14.0) | 1431 (33.3) | 2101 (50.7) | Â |
Co-morbidities | Â | Â | Â | Â | Â |
Diabetes, n (%) | 1714 (17.9) | 375 (64.7) | 1143 (27.1) | 107 (2.6) | <0.001* |
Peripheral vascular disease, n (%) | 317 (3.3) | 121 (20.5) | 168 (3.9) | 24 (0.6) | <0.001* |
Cerebrovascular disease, n (%) | 428 (4.5) | 122 (20.6) | 297 (6.9) | 0 | <0.001* |
Asthma or COPD, n (%) | 1166 (12.2) | 147 (24.9) | 651 (15.1) | 358 (8.6) | <0.001* |
Chronic renal failure, n (%) | 289 (3.0) | 235 (39.8) | 45 (1.1) | 8 (0.2) | <0.001* |
Heart failure, n (%) | 212 (2.2) | 203 (34.4) | 0 | 6 (0.1) | <0.001* |
Hypertension, n (%) | 4078 (42.6) | 408 (69.0) | 3295 (76.6) | 337 (8.1) | <0.001* |
Previous MI, n (%) | 1522 (15.9) | 384 (65.0) | 1006 (23.4) | 114 (2.8) | <0.001* |
Angina, n (%) | 1792 (18.7) | 374 (63.3) | 1322 (30.7) | 80 (1.9) | <0.001* |
Previous PCI, n (%) | 899 (9.4) | 169 (28.7) | 617 (14.4) | 98 (2.4) | <0.001* |
CABG surgery, n (%) | 643 (6.7) | 152 (25.8) | 452 (10.5) | 29 (0.7) | <0.001* |
Discharge medications | Â | Â | Â | Â | Â |
Aspirin, n (%) | 8147 (85.2) | 464 (79.2) | 3626 (84.7) | 3636 (87.9) | <0.001* |
ACE inhibitors, n (%) | 7609 (79.5) | 418 (71.3) | 3389 (79.2) | 3436 (83.1) | <0.001* |
Beta-blockers, n (%) | 7592 (79.7) | 430 (73.4) | 3340 (78. 0) | 3439 (83.1) | <0.001* |
Statin, n (%) | 8140 (85.1) | 477 (81.4) | 3619 (84.6) | 3636 (87.9) | <0.001* |
Rehabilitation | Â | Â | Â | Â | Â |
Cardiac rehabilitation, n (%) | 8509 (88.9) | 502 (85.1) | 3854 (90.3) | 3877 (94.5) | <0.001* |